{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:09:43Z","timestamp":1772165383783,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1465-9921-15-77","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:18:14Z","timestamp":1548202694000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO)"],"prefix":"10.1186","volume":"15","author":[{"given":"Andrea","family":"Rossi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Guerriero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Corrado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,8]]},"reference":[{"key":"1519_CR1","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJMra1201534","volume":"369","author":"CJL Murray","year":"2013","unstructured":"Murray CJL, Lopez AD: Measuring the global burden of disease. New Eng J Med. 2013, 369: 448-457.","journal-title":"New Eng J Med"},{"key":"1519_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7326\/0003-4819-155-3-201108020-00008","volume":"155","author":"A Qaseem","year":"2011","unstructured":"Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Sch\u00fcnemann H, Wedzicha W, MacDonald R, Shekelle P, American College of Physicians; American College of Chest Physicians; American Thoracic Society; European Respiratory Society: Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society and European Respiratory Society. Ann Intern Med. 2011, 155: 179-191.","journal-title":"Ann Intern Med"},{"key":"1519_CR3","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1183\/09031936.00048912","volume":"40","author":"JA Wedzicha","year":"2012","unstructured":"Wedzicha JA, Decramer M, Seemugal TA: The role of bronchodilator treatment in the prevention of exacerbations of COPD. Eur Respir J. 2012, 40: 1545-1554.","journal-title":"Eur Respir J"},{"key":"1519_CR4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","volume":"187","author":"J Vestbo","year":"2013","unstructured":"Vestbo J, Hurd SS, Agust\u00ed AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013, 187: 347-365.","journal-title":"Am J Respir Crit Care Med"},{"key":"1519_CR5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.rmed.2012.03.008","volume":"106","author":"A Corrado","year":"2012","unstructured":"Corrado A, Rossi A: How far is real life from COPD therapy guidelines? An Italian observational study. Respir Med. 2012, 106: 989-997.","journal-title":"Respir Med"},{"key":"1519_CR6","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1183\/09031936.01.00213701","volume":"18","author":"N Roche","year":"2001","unstructured":"Roche N, Lepage T, Bourcereau J, Terrioux P: Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease. Eur Respir J. 2001, 18: 903-908.","journal-title":"Eur Respir J"},{"key":"1519_CR7","first-page":"89","volume":"5","author":"J Seaman","year":"2010","unstructured":"Seaman J, Leonard AC, Panos RJ: Health care utilization history, GOLD guidelines, and respiratory medication prescriptions in patients with COPD. Int J COPD. 2010, 5: 89-97.","journal-title":"Int J COPD"},{"key":"1519_CR8","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","volume":"176","author":"KF Rabe","year":"2007","unstructured":"Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J: Global initiative for chronic obstructive lung disease: global strategies for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007, 176: 532-555.","journal-title":"Am J Respir Crit Care Med"},{"key":"1519_CR9","unstructured":"National Clinical Guideline Centre: Chronic Obstructive Pulmonary Disease: Management Of Chronic Obstructive Pulmonary Disease In Adults In Primary And Secondary Care. London, UK: National Clinical Guideline Centre, Available from: \n                    https:\/\/www.nice.org.uk\/guidance\/CG101\/chapter\/Introduction\n                    \n                  ."},{"key":"1519_CR10","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1183\/09031936.00118912","volume":"41","author":"M Miravitlles","year":"2013","unstructured":"Miravitlles M, Soler-Catalu\u00f1a JJ, Calle M, Soriano JB: Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice. Eur Respir J. 2013, 41: 1252-1256.","journal-title":"Eur Respir J"},{"key":"1519_CR11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1378\/chest.09-1305","volume":"137","author":"R Agarwal","year":"2010","unstructured":"Agarwal R, Aggarwal AN, Gupta D, Jindal SK: Inhaled corticosteroids vs placebo for preventing COPD exacerbations: a systematic review and metaregression of randomized controlled trial. Chest. 2010, 137: 318-325.","journal-title":"Chest"},{"key":"1519_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4104\/pcrj.2012.00092","volume":"22","author":"D Price","year":"2013","unstructured":"Price D, Yawn B, Brusselle G, Rossi A: Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD. Prim Care Respir J. 2013, 22: 92-100.","journal-title":"Prim Care Respir J"},{"key":"1519_CR13","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1056\/NEJMoa063070","volume":"356","author":"PM Calverley","year":"2007","unstructured":"Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J: TORCH investigators: salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007, 356: 775-789.","journal-title":"N Engl J Med"},{"key":"1519_CR14","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/thoraxjnl-2012-202709","volume":"68","author":"S Suissa","year":"2013","unstructured":"Suissa S: Number needed to treat in COPD: exacerbations versus pneumonias. Thorax. 2013, 68: 540-543.","journal-title":"Thorax"},{"key":"1519_CR15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/joim.12067","volume":"273","author":"K Larsson","year":"2013","unstructured":"Larsson K, Janson C, Lisspers K, J\u00f8rgensen L, Stratelis G, Telg G, St\u00e4llberg B, Johansson G: Combination of budesonide\/formoterol more effective than fluticasone\/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study. J Intern Med. 2013, 273: 584-594.","journal-title":"J Intern Med"},{"key":"1519_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2147\/COPD.S42366","volume":"8","author":"BP Yawn","year":"2013","unstructured":"Yawn BP, Li YF, Tian HJ, Zhang J, Arcona S, Kahler KH: Inhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis. Int J COPD. 2013, 8: 295-304.","journal-title":"Int J COPD"},{"key":"1519_CR17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1164\/ajrccm.164.3.2002052","volume":"164","author":"A O\u2019Brien","year":"2001","unstructured":"O\u2019Brien A, Russo-Magno P, Karki A, Hiranniramol S, Hardin M, Kaszuba M, Sherman C, Rounds S: Effects of withdrawal of inhaled steroids in men with severe irreversible airflow obstruction. Am J Respir Crit Care Med. 2001, 164: 365-371.","journal-title":"Am J Respir Crit Care Med"},{"key":"1519_CR18","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1164\/rccm.200206-512OC","volume":"166","author":"P van der Valk","year":"2002","unstructured":"van der Valk P, Monninkhof E, van der Palen J, Zielhuis G, van Herwaarden C: Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study. Am J Respir Crit Care Med. 2002, 166: 1358-1363.","journal-title":"Am J Respir Crit Care Med"},{"key":"1519_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1465-9921-8-93","volume":"8","author":"AB Choudhury","year":"2007","unstructured":"Choudhury AB, Dawson CM, Kilvington HE, Eldridge S, James WY, Wedzicha JA, Feder GS, Griffiths CJ: Withdrawal of inhaled corticosteroids in people with COPD in primary care: a randomized controlled trial. Respir Res. 2007, 8: 93-","journal-title":"Respir Res"},{"key":"1519_CR20","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/thx.2004.034280","volume":"60","author":"EF Wouters","year":"2005","unstructured":"Wouters EF, Postma DS, Fokkens B, Hop WC, Prins J, Kuipers AF, Pasma HR, Hensing CA, Creutzberg EC: COSMIC (COPD and seretide: a multi-center intervention and characterization) study group: withdrawal of fluticasone propionate from combined salmeterol\/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomized controlled trial. Thorax. 2005, 60: 480-487.","journal-title":"Thorax"},{"key":"1519_CR21","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1183\/09031936.00006710","volume":"35","author":"DD Sin","year":"2010","unstructured":"Sin DD, Man SFP: Steroids in COPD: still up in the air?. Eur Respir J. 2010, 35: 949-951.","journal-title":"Eur Respir J"},{"issue":"Suppl 1","key":"1519_CR22","first-page":"3","volume":"31","author":"G Bettoncelli","year":"2014","unstructured":"Bettoncelli G, Blasi F, Brusasco V, Centanni S, Corrado A, De Benedetto F, De Michele F, Di Maria GU, Donner CF, Falcone F, Mereu C, Nardini S, Pasqua F, Polverino M, Rossi A, Sanguinetti CM: The clinical and integrated management of COPD. An official document of AIMAR (Interdisciplinary Association for research in Lung Disease), AIPO (Italian Association of Hospital Pulmonologists), SIMER (Italian Society of Respiratory Medicine), SIMG (Italian Society of General Medicine). Sarcoidosis Vasc Diffuse Lung Dis. 2014, 31 (Suppl 1): 3-21.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"1519_CR23","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1183\/09031936.95.08081398","volume":"8","author":"NM Siafakas","year":"1995","unstructured":"Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS, Rees J, On behalf of the Task Force: Optimal assessment and management of chronic obstructive pulmonary disease (COPD). A consensus statement of the European respiratory society (ERS). Eur Respir J. 1995, 8: 1398-1420.","journal-title":"Eur Respir J"},{"key":"1519_CR24","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1183\/09031936.05.00035205","volume":"26","author":"R Pellegrino","year":"2005","unstructured":"Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J: Interpretative strategies for lung function tests. Eur Respir J. 2005, 26: 948-968.","journal-title":"Eur Respir J"},{"key":"1519_CR25","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1378\/chest.10-2052","volume":"138","author":"P Enright","year":"2010","unstructured":"Enright P, Brusasco V: Counterpoint: should we abandon FEV1\/FVC, 0.70 to detect airway obstruction? Yes. Chest. 2010, 138: 1040-1042.","journal-title":"Chest"},{"issue":"Suppl.16","key":"1519_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1183\/09041950.005s1693","volume":"6","author":"PH Quanjer","year":"1993","unstructured":"Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and ventilator flows. Report working party \u201cstandardization of lung function tests\u201d. European community for steel and coal and European respiratory Society. Eur Respir J. 1993, 6 (Suppl.16): 5-40.","journal-title":"Eur Respir J"},{"key":"1519_CR27","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","volume":"363","author":"JR Hurst","year":"2010","unstructured":"Hurst JR, Vestbo J, Anzueto A, Locantore N, M\u00fcllerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EF, Wedzicha JA: Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) investigators: susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010, 363: 1128-1138.","journal-title":"N Engl J Med"},{"key":"1519_CR28","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1183\/09031936.00102509","volume":"34","author":"PW Jones","year":"2009","unstructured":"Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N: Development and first validation of the COPD assessment test. Eur Respir J. 2009, 34: 648-654.","journal-title":"Eur Respir J"},{"key":"1519_CR29","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1164\/rccm.200707-1064OC","volume":"177","author":"D Ofir","year":"2008","unstructured":"Ofir D, Laveneziana P, Webb KA, Lam YM, O\u2019Donnell DE: Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008, 177: 622-629.","journal-title":"Am J Respir Crit Care Med"},{"key":"1519_CR30","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S0140-6736(09)61298-8","volume":"374","author":"M Decramer","year":"2009","unstructured":"Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP: UPLIFT investigators: effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomized controlled trial. Lancet. 2009, 374: 1171-1178.","journal-title":"Lancet"},{"key":"1519_CR31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1465-9921-12-107","volume":"12","author":"NJ Nadeem","year":"2011","unstructured":"Nadeem NJ, Taylor SJC, Eldridge SM: Withdrawal of inhaled corticosteroids in individuals with COPD \u2013 a systematic review and comment on trial methodology. Respir Res. 2011, 12: 107-","journal-title":"Respir Res"},{"key":"1519_CR32","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1136\/thoraxjnl-2011-201140","volume":"67","author":"DA Mahler","year":"2012","unstructured":"Mahler DA, D\u2019Urzo A, Bateman ED, Ozkan SA, White T, Peckitt C, Lassen C, Kramer B: INTRUST-1 and INTRUST-2 study investigators: concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomized, double-blind comparison. Thorax. 2012, 67: 781-788.","journal-title":"Thorax"},{"key":"1519_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S2213-2600(12)70052-8","volume":"1","author":"CF Vogelmeier","year":"2013","unstructured":"Vogelmeier CF, Bateman ED, Pallante J, Alagappan VKT, D\u2019Andrea P, Chen H, Banerji D: Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol\u2013fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study. Lancet Respir Med. 2013, 1: 51-60.","journal-title":"Lancet Respir Med"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-15-77.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:25:32Z","timestamp":1548203132000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/1465-9921-15-77"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,8]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1519"],"URL":"https:\/\/doi.org\/10.1186\/1465-9921-15-77","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718486348.793532759","asserted-by":"object"}]},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,8]]},"assertion":[{"value":"15 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"77"}}